GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
Osteoporosis (OP) is a serious problem to patients who have long taken glucocorticoids. In the past two decade, much knowledge has been accumulated about the epidemiology of the disease and drugs with proven efficacy for its prevention and treatment have emerged. However, a large number of studies s...
Main Author: | Irina Aleksandrovna Baranova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2010-06-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/295 |
Similar Items
-
glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
by: Natalia Vladimirovna Toroptsova, et al.
Published: (2013-12-01) -
Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01) -
New possibilities for the treatment of glucocorticoid-induced osteoporosis
by: I.A. Baranova
Published: (2014-05-01) -
Osteoporosis as a result of the long-term administration of glucocorticoids in patients suffering from acantholytic pemphigus
by: M. A. Ufimtseva, et al.
Published: (2017-08-01) -
NEW ASPECTS IN THE DIAGNOSIS AND TREATMENT OF GLUCOCORTICOID OSTEOPOROSIS
by: I A Baranova, et al.
Published: (2013-12-01)